Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarbjit Singh

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockersSarbjit Singh, Veeraswamy Gajulapati, Kondaji Gajulapati, et al.
European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Frontiers in Allergy|December 24, 2025
Quality of life is impaired in shrimp allergic adults and caregiversMelissa L Hearrell, Sara Anvari, Sharon Chinthrajah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2015
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, et al.
Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.
Scientific Reports|February 28, 2023
Cdk5 mediates rotational force-induced brain injuryAlan Umfress, Ayanabha Chakraborti, Suma Priya Sudarsana Devi, et al.
RSC Advances|April 4, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growthJohn Victor Napoleon, Satish Sagar, Sydney P Kubica, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockersSarbjit Singh, Veeraswamy Gajulapati, Kondaji Gajulapati, et al.
European Journal of Medicinal Chemistry|June 7, 2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapySatish Sagar, Sarbjit Singh, Jayapal Reddy Mallareddy, et al.
Frontiers in Allergy|December 24, 2025
Quality of life is impaired in shrimp allergic adults and caregiversMelissa L Hearrell, Sara Anvari, Sharon Chinthrajah, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2015
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, et al.
Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.
Scientific Reports|February 28, 2023
Cdk5 mediates rotational force-induced brain injuryAlan Umfress, Ayanabha Chakraborti, Suma Priya Sudarsana Devi, et al.
RSC Advances|April 4, 2025
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degradersJayapal Reddy Mallareddy, Lin Yang, Wan-Hsin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growthJohn Victor Napoleon, Satish Sagar, Sydney P Kubica, et al.
Pageof 8